Table 1.
Eligibility and exclusion criteria of main cohort including study and control group.
Fig 1.
Patient flow diagram of exclusion criteria being applied to thrombocytosis group and control group.
MPN, myeloproliferative neoplasm.
Fig 2.
Chart demonstrating cancer incidence in control group and thrombocytosis group with 95% confidence intervals shown.
Table 2.
Reliability and validity of all proposed tests for cancer detection.
Fig 3.
Flowchart depiction of formation of validation cohort with exclusion criteria applied.
Number of cancers found within cohort shown with 95% confidence intervals (CI).
Fig 4.
Histogram displaying distribution of platelet count in cancer patients in main and validation cohorts.
Vertical line represents 450x109, the upper limit of the reference range for platelet count in many laboratories.
Table 3.
Cancer stage, site and site of metastasis amongst all cancer patients in both main and validation cohorts combined.